Collection 2 (Sep 2021 - Aug 2022) Articles

Articles
Twelve Variants Polygenic Score for Low-Density Lipoprotein Cholesterol Distribution in a Large Cohort of Patients With Clinically Diagnosed Familial Hypercholesterolemia With or Without Causative Mutations
Olmastroni E, Gazzotti M, Arca M, et al.
Journal:
J Am Heart Assoc

First published: March 24, 2022 DOI: 10.1161/JAHA.121.023668
View
- Share
Articles
Effect of Pelacarsen on Lipoprotein(a) Cholesterol and Corrected Low-Density Lipoprotein Cholesterol
Yeang C, Karwatowska-Prokopczuk E, Su F, et al.
Journal:
J Am Coll Cardiol

First published: March 22, 2022 DOI: 10.1016/j.jacc.2021.12.032
View
- Share
Articles
Lipoprotein(a) levels from childhood to adulthood: Data in nearly 3,000 children who visited a pediatric lipid clinic
de Boer LM, Hof MH, Wiegman A, et al.
Journal:
Atherosclerosis

First published: March 21, 2022 DOI: 10.1016/j.atherosclerosis.2022.03.004
View
- Share
Articles
The Trajectory of Lipoprotein(a) During the Peri- and Early Postinfarction Period and the Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition
Vavuranakis MA, Jones SR, Ziogos E, et al.
Journal:
Am J Cardiol

First published: March 21, 2022 DOI: 10.1016/j.amjcard.2022.01.058
View
- Share
Articles
Diagnosis of familial hypercholesterolemia in a large cohort of Italian genotyped hypercholesterolemic patients
Noto D, Spina R, Giammanco A, et al.
Journal:
Atherosclerosis

First published: March 16, 2022 DOI: 10.1016/j.atherosclerosis.2022.03.012
View
- Share
Articles
Effect of Evolocumab on Changes in Coronary Plaque Phenotype and Burden in Statin-Treated Patients Following Myocardial Infarction
Nicholls S, Kataoka Y, Nissen S, et al.
Journal:
J Am Coll Cardiol

First published: March 16, 2022 DOI: 10.1016/j.jcmg.2022.03.002
View
- Share
Articles
Key Questions About Familial Hypercholesterolemia: JACC Review Topic of the Week
Sniderman AD, Glavinovic T, Thanassoulis G
Journal:
J Am Coll Cardiol

First published: March 15, 2022 DOI: 10.1016/j.jacc.2022.01.010
View
- Share
Articles
A Tale of Two New Targets for Hypertriglyceridaemia: Which Choice of Therapy?
Ward NC, Chan DC, Watts GF
Journal:
BioDrugs

First published: March 14, 2022 DOI: 10.1007/s40259-022-00520-2
View
- Share
Articles
Lipoprotein(a): a risk factor for atherosclerosis and an emerging therapeutic target
Di Fusco SA, Arca M, Scicchitano P, et al.
Journal:
Heart

First published: March 14, 2022 DOI: 10.1136/heartjnl-2021-320708
View
- Share
Articles
Efficacy and safety of bempedoic acid in patients not receiving statins in phase 3 clinical trials
Laufs U, Ballantyne CM, Banach M, et al.
Journal:
J Clin Lipidol

First published: March 13, 2022 DOI: 10.1016/j.jacl.2022.03.001
View
- Share
Articles
Lipoprotein(a) Serum Levels Predict Pulse Wave Velocity in Subjects in Primary Prevention for Cardiovascular Disease with Large Apo(a) Isoforms: Data from the Brisighella Heart Study
Cicero AFG, Fogacci F, Derosa G, et al.
Journal:
Biomedicines

First published: March 11, 2022 DOI: 10.3390/biomedicines10030656
View
- Share
Articles
Association between lipoprotein(a) concentrations and atherosclerotic cardiovascular disease risk in patients with familial hypercholesterolemia: an analysis from the HELLAS-FH
Anagnostis P, Rizos CV, Skoumas I, et al.
Journal:
Endocrine

First published: March 9, 2022 DOI: 10.1007/s12020-022-03013-y
View
- Share

1 … 5 6 7 8 9 … 14

Collection 2 (Sep 2021 - Aug 2022) Articles

Articles

Twelve Variants Polygenic Score for Low-Density Lipoprotein Cholesterol Distribution in a Large Cohort of Patients With Clinically Diagnosed Familial Hypercholesterolemia With or Without Causative Mutations

Olmastroni E, Gazzotti M, Arca M, et al.

Articles

Effect of Pelacarsen on Lipoprotein(a) Cholesterol and Corrected Low-Density Lipoprotein Cholesterol

Yeang C, Karwatowska-Prokopczuk E, Su F, et al.

Articles

Lipoprotein(a) levels from childhood to adulthood: Data in nearly 3,000 children who visited a pediatric lipid clinic

de Boer LM, Hof MH, Wiegman A, et al.

Articles

The Trajectory of Lipoprotein(a) During the Peri- and Early Postinfarction Period and the Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition

Vavuranakis MA, Jones SR, Ziogos E, et al.

Articles

Diagnosis of familial hypercholesterolemia in a large cohort of Italian genotyped hypercholesterolemic patients

Noto D, Spina R, Giammanco A, et al.

Articles

Effect of Evolocumab on Changes in Coronary Plaque Phenotype and Burden in Statin-Treated Patients Following Myocardial Infarction

Nicholls S, Kataoka Y, Nissen S, et al.

Articles

Key Questions About Familial Hypercholesterolemia: JACC Review Topic of the Week

Sniderman AD, Glavinovic T, Thanassoulis G

Articles

A Tale of Two New Targets for Hypertriglyceridaemia: Which Choice of Therapy?

Ward NC, Chan DC, Watts GF

Articles

Lipoprotein(a): a risk factor for atherosclerosis and an emerging therapeutic target

Di Fusco SA, Arca M, Scicchitano P, et al.

Articles

Efficacy and safety of bempedoic acid in patients not receiving statins in phase 3 clinical trials

Laufs U, Ballantyne CM, Banach M, et al.

Articles

Lipoprotein(a) Serum Levels Predict Pulse Wave Velocity in Subjects in Primary Prevention for Cardiovascular Disease with Large Apo(a) Isoforms: Data from the Brisighella Heart Study

Cicero AFG, Fogacci F, Derosa G, et al.

Articles

Association between lipoprotein(a) concentrations and atherosclerotic cardiovascular disease risk in patients with familial hypercholesterolemia: an analysis from the HELLAS-FH

Anagnostis P, Rizos CV, Skoumas I, et al.

Articles

Twelve Variants Polygenic Score for Low-Density Lipoprotein Cholesterol Distribution in a Large Cohort of Patients With Clinically Diagnosed Familial Hypercholesterolemia With or Without Causative Mutations

Olmastroni E, Gazzotti M, Arca M, et al.

Share

Articles

Effect of Pelacarsen on Lipoprotein(a) Cholesterol and Corrected Low-Density Lipoprotein Cholesterol

Yeang C, Karwatowska-Prokopczuk E, Su F, et al.

Share

Articles

Lipoprotein(a) levels from childhood to adulthood: Data in nearly 3,000 children who visited a pediatric lipid clinic

de Boer LM, Hof MH, Wiegman A, et al.

Share

Articles

The Trajectory of Lipoprotein(a) During the Peri- and Early Postinfarction Period and the Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition

Vavuranakis MA, Jones SR, Ziogos E, et al.

Share

Articles

Diagnosis of familial hypercholesterolemia in a large cohort of Italian genotyped hypercholesterolemic patients

Noto D, Spina R, Giammanco A, et al.

Share

Articles

Effect of Evolocumab on Changes in Coronary Plaque Phenotype and Burden in Statin-Treated Patients Following Myocardial Infarction

Nicholls S, Kataoka Y, Nissen S, et al.

Share

Articles

Key Questions About Familial Hypercholesterolemia: JACC Review Topic of the Week

Sniderman AD, Glavinovic T, Thanassoulis G

Share

Articles

A Tale of Two New Targets for Hypertriglyceridaemia: Which Choice of Therapy?

Ward NC, Chan DC, Watts GF

Share

Articles

Lipoprotein(a): a risk factor for atherosclerosis and an emerging therapeutic target

Di Fusco SA, Arca M, Scicchitano P, et al.

Share

Articles

Efficacy and safety of bempedoic acid in patients not receiving statins in phase 3 clinical trials

Laufs U, Ballantyne CM, Banach M, et al.

Share

Articles

Lipoprotein(a) Serum Levels Predict Pulse Wave Velocity in Subjects in Primary Prevention for Cardiovascular Disease with Large Apo(a) Isoforms: Data from the Brisighella Heart Study

Cicero AFG, Fogacci F, Derosa G, et al.

Share

Articles

Association between lipoprotein(a) concentrations and atherosclerotic cardiovascular disease risk in patients with familial hypercholesterolemia: an analysis from the HELLAS-FH

Anagnostis P, Rizos CV, Skoumas I, et al.

Share